WallStreetZenWallStreetZen

NASDAQ: LENZ
Lenz Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for LENZ

Based on 3 analysts offering 12 month price targets for Lenz Therapeutics Inc

Min Forecast
$36.00+60%
Avg Forecast
$37.00+64.44%
Max Forecast
$38.00+68.89%

Should I buy or sell LENZ stock?

Based on 3 analysts offering ratings for Lenz Therapeutics Inc.

Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although LENZ's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates LENZ as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their LENZ stock forecasts and price targets.

LENZ stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-11-07
lockedlocked$00.00+00.00%2024-09-27
lockedlocked$00.00+00.00%2024-08-15

1 of 1

Forecast return on equity

Is LENZ forecast to generate an efficient return?

Company
18.75%
Industry
229.92%
Market
67.05%
LENZ's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LENZ forecast to generate an efficient return on assets?

Company
18.02%
Industry
35.19%
LENZ is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LENZ earnings per share forecast

What is LENZ's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$2.54
Avg 2 year Forecast
-$2.00
Avg 3 year Forecast
-$0.33

LENZ revenue forecast

What is LENZ's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$8.5M
Avg 2 year Forecast
$53.2M
Avg 3 year Forecast
$125.7M

LENZ vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LENZ$22.50$37.00+64.44%Strong Buy
DNA$10.83$10.00-7.66%Strong Buy
CAPR$13.70$41.67+204.14%Strong Buy
IMNM$9.99$28.00+180.28%Strong Buy
ABUS$3.20$5.50+71.88%Strong Buy
View Top Biotech Stocks

Lenz Therapeutics Stock Forecast FAQ

Is Lenz Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: LENZ) stock is to Strong Buy LENZ stock.

Out of 3 analysts, 1 (33.33%) are recommending LENZ as a Strong Buy, 2 (66.67%) are recommending LENZ as a Buy, 0 (0%) are recommending LENZ as a Hold, 0 (0%) are recommending LENZ as a Sell, and 0 (0%) are recommending LENZ as a Strong Sell.

If you're new to stock investing, here's how to buy Lenz Therapeutics stock.

What is LENZ's earnings growth forecast for 2025-2027?

(NASDAQ: LENZ) Lenz Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.98%.

Lenz Therapeutics's earnings in 2025 is -$60,035,000.On average, 6 Wall Street analysts forecast LENZ's earnings for 2025 to be -$69,805,514, with the lowest LENZ earnings forecast at -$85,802,783, and the highest LENZ earnings forecast at -$58,576,900. On average, 4 Wall Street analysts forecast LENZ's earnings for 2026 to be -$54,864,280, with the lowest LENZ earnings forecast at -$75,627,453, and the highest LENZ earnings forecast at -$36,576,186.

In 2027, LENZ is forecast to generate -$9,075,294 in earnings, with the lowest earnings forecast at -$38,226,240 and the highest earnings forecast at $22,550,731.

What is LENZ's revenue growth forecast for 2025-2027?

(NASDAQ: LENZ) Lenz Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 50.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.63%.

Lenz Therapeutics's revenue in 2025 is $0.On average, 5 Wall Street analysts forecast LENZ's revenue for 2025 to be $233,977,589, with the lowest LENZ revenue forecast at $151,254,906, and the highest LENZ revenue forecast at $338,260,972. On average, 5 Wall Street analysts forecast LENZ's revenue for 2026 to be $1,463,652,474, with the lowest LENZ revenue forecast at $1,146,512,187, and the highest LENZ revenue forecast at $1,738,606,392.

In 2027, LENZ is forecast to generate $3,456,229,604 in revenue, with the lowest revenue forecast at $2,887,593,660 and the highest revenue forecast at $3,803,373,364.

What is LENZ's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: LENZ) forecast ROA is 18.02%, which is lower than the forecast US Biotechnology industry average of 35.19%.

What is LENZ's Price Target?

According to 3 Wall Street analysts that have issued a 1 year LENZ price target, the average LENZ price target is $37.00, with the highest LENZ stock price forecast at $38.00 and the lowest LENZ stock price forecast at $36.00.

On average, Wall Street analysts predict that Lenz Therapeutics's share price could reach $37.00 by Nov 7, 2025. The average Lenz Therapeutics stock price prediction forecasts a potential upside of 64.44% from the current LENZ share price of $22.50.

What is LENZ's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: LENZ) Lenz Therapeutics's current Earnings Per Share (EPS) is -$4.95. On average, analysts forecast that LENZ's EPS will be -$2.54 for 2025, with the lowest EPS forecast at -$3.12, and the highest EPS forecast at -$2.13. On average, analysts forecast that LENZ's EPS will be -$2.00 for 2026, with the lowest EPS forecast at -$2.75, and the highest EPS forecast at -$1.33. In 2027, LENZ's EPS is forecast to hit -$0.33 (min: -$1.39, max: $0.82).

What is LENZ's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: LENZ) forecast ROE is 18.75%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.